Cytokinetics Inc (CYTK)

Deferred Revenue

$1.65M

Quarterly · Period ending: · USD

CYTK logo

CYTK Deferred Revenue

Latest reported$1.65M
CYTK Quarterly Deferred Revenue ($2.80M → $1.65M)
High-resolution chart · PNG

CYTK deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytokinetics Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
1,653,000
1,653,000
1,612,000
1,612,000
1,344,000
52,370,000
52,370,000
0
-38,316,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,139,000
11,828,000
12,944,000
15,757,000
15,652,000
8,132,000
7,842,000
9,572,000
9,570,000
7,942,000
10,974,000
8,060,000
10,497,000
13,559,000
15,911,000
20,858,000
21,367,000
20,993,000
19,942,000
17,042,000
5,284,000
8,984,000
10,396,000
14,701,000
33,322,000
25,529,000
43,000
76,000
129,000
0
0
0
0
263,000
17,000
0
0
0
217,000
751,000
708,000
0
12,297,000
12,296,000
12,234,000
12,234,000
12,234,000
12,234,000
12,234,000
12,234,000
12,234,000
12,234,000
6,424,000
5,502,000
700,000
1,400,000
2,100,000
2,800,000
4,299,000
2,800,000
2,800,000
2,800,000
2,800,000
2,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.